Targeting Amyloid and Tau: Current and Emerging Therapies

The pathological accumulation of amyloid-beta plaques and tau tangles remains a hallmark of Alzheimer’s disease. This session will explore current therapies targeting amyloid and tau, as well as novel strategies in development. The discussion will cover FDA-approved drugs, such as anti-amyloid monoclonal antibodies, and new clinical trial results from drugs aiming to halt or reverse tau pathology. By addressing these core pathologies, this track will focus on how therapeutic interventions may modify disease progression.
 

    Related Conference of Targeting Amyloid and Tau: Current and Emerging Therapies

    September 22-23, 2025

    6th Annual Congress on Psychiatry

    Paris, France
    October 27-28, 2025

    39th International Conference on Psychiatry and Mental Health

    Amsterdam, Netherlands
    November 10-11, 2025

    International Congress on Cognitive Psychotherapy

    Vancouver, Canada
    November 10-11, 2025

    5th Annual Psychiatrists and Psychologists Meet

    Vancouver, Canada
    November 24-25, 2025

    5thAnnual Congress on Mental Health & Psychiatry

    Barcelona, Spain
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France
    February 16-17, 2026

    6th Annual Congress on Mental Health

    Paris, France
    April 20-21, 2026

    33rd World Psychiatrists and Psychologists Meet

    Rome, Italy
    May 27-28, 2026

    8th European Autism Congress

    Paris, France

    Targeting Amyloid and Tau: Current and Emerging Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in